Venclexta (AbbVie Inc.)
Welcome to the PulseAid listing for the Venclexta drug offered from AbbVie Inc.. This BCL-2 Inhibitor [EPC],Increased Cellular Death [PE],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Venetoclax |
| SUBSTANCE NAME: | VENETOCLAX |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | BCL-2 Inhibitor [EPC],Increased Cellular Death [PE],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-04-11 |
| END MARKETING DATE: | 0000-00-00 |
Venclexta HUMAN PRESCRIPTION DRUG Details:
| Item Description | Venclexta from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2016-04-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-0561_472f27dd-eb29-8ccc-58ea-e8f0443ccf23 |
| PRODUCT NDC: | 0074-0561 |
| APPLICATION NUMBER: | NDA208573 |
Other VENETOCLAX Pharmaceutical Manufacturers / Labelers:
